MariMed Acquires NJ-Based BSC Group Cannabis Firm;
Post# of 63
(Total Views: 359)
Posted On: 12/08/2018 3:10:10 PM
MariMed Acquires NJ-Based BSC Group Cannabis Firm; Strengthens Operations, Branding Teams
Oct 29, 2018 | PRESS RELEASES
NORWOOD, MA, October 29, 2018 – MariMed Inc., a multi-state cannabis organization that develops, owns and manages cannabis facilities and branded products lines, announced today that it has finalized the acquisition of BSC Group, a highly respected cannabis firm headquartered in New Jersey that over the last three years has been engaged in competitive licensing, consulting and operations management across the country.
BSC founders and managing partners, Brian Staffa and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise, resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied sciences.
Brian and Amber will help guide MariMed’s strategy for new markets like New Jersey, where lawmakers inch closer to consensus on adult use legislation. New Jersey represents just one of the markets being eyed by MariMed as they aggressively pursue new opportunities across the U.S. and abroad with their added bandwidth.
“Our team has worked with BSC Group on various projects in the past, and their laser focus made them an ideal partner to help fuel MariMed’s forward momentum,” said MariMed CEO Bob Fireman. “We are excited to bring on Amber and Brian, who have seasoned cannabis operations, corporate strategy, branding and marketing expertise. An organization is only as good as the people in it. The Staffas share our vision and work ethic and will be a great addition to our team.”
Brian Staffa noted, “This partnership with MariMed represented the right opportunity to solidify our industry presence for the long haul, positioning ourselves as an integral element of an established team with long term viability. They share our belief that the only path to market maturation and true consumer satisfaction is via an unwavering commitment to data-driven and documented, scaled processes.
Brian Staffa will bolster MariMed’s operations, coming on as VP of Cultivation & Manufacturing, leveraging nearly 10 years of commercial cannabis experience in over 150 facilities in 25 states and countries. Staffa’s audits of facility operations often reveal opportunities for optimizing efficiency, translating to increased top and bottom line growth.
With a substantial background in education, curriculum development, branding and consumer buying habits, Amber Staffa will join MariMed as VP of Branding & Marketing, fueling the potential for product development and partnership opportunities that will project MariMed’s voice and grow its branded product footprint.
BSC Group will become a wholly owned subsidiary of MariMed, and will continue to service its clients with an even larger arsenal of resources.
#MedicatedByMarimed:
Twitter: @MariMedInc
Facebook: @MariMedInc
Oct 29, 2018 | PRESS RELEASES
NORWOOD, MA, October 29, 2018 – MariMed Inc., a multi-state cannabis organization that develops, owns and manages cannabis facilities and branded products lines, announced today that it has finalized the acquisition of BSC Group, a highly respected cannabis firm headquartered in New Jersey that over the last three years has been engaged in competitive licensing, consulting and operations management across the country.
BSC founders and managing partners, Brian Staffa and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise, resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied sciences.
Brian and Amber will help guide MariMed’s strategy for new markets like New Jersey, where lawmakers inch closer to consensus on adult use legislation. New Jersey represents just one of the markets being eyed by MariMed as they aggressively pursue new opportunities across the U.S. and abroad with their added bandwidth.
“Our team has worked with BSC Group on various projects in the past, and their laser focus made them an ideal partner to help fuel MariMed’s forward momentum,” said MariMed CEO Bob Fireman. “We are excited to bring on Amber and Brian, who have seasoned cannabis operations, corporate strategy, branding and marketing expertise. An organization is only as good as the people in it. The Staffas share our vision and work ethic and will be a great addition to our team.”
Brian Staffa noted, “This partnership with MariMed represented the right opportunity to solidify our industry presence for the long haul, positioning ourselves as an integral element of an established team with long term viability. They share our belief that the only path to market maturation and true consumer satisfaction is via an unwavering commitment to data-driven and documented, scaled processes.
Brian Staffa will bolster MariMed’s operations, coming on as VP of Cultivation & Manufacturing, leveraging nearly 10 years of commercial cannabis experience in over 150 facilities in 25 states and countries. Staffa’s audits of facility operations often reveal opportunities for optimizing efficiency, translating to increased top and bottom line growth.
With a substantial background in education, curriculum development, branding and consumer buying habits, Amber Staffa will join MariMed as VP of Branding & Marketing, fueling the potential for product development and partnership opportunities that will project MariMed’s voice and grow its branded product footprint.
BSC Group will become a wholly owned subsidiary of MariMed, and will continue to service its clients with an even larger arsenal of resources.
#MedicatedByMarimed:
Twitter: @MariMedInc
Facebook: @MariMedInc
(0)
(0)MariMed Inc. (MRMD) Stock Research Links
Scroll down for more posts ▼